Indegene Limited has reported its unaudited financial results for the second quarter and half-year ended September 30, 2026. The company posted a consolidated profit of ₹1,123 million for the quarter, marking a substantial increase. The Board also approved unaudited financial results and noted significant resignations, including that of Mr. Mark Francis Dzialga and Ms. Srishti Ramesh Kaushik.
Indegene Reports Strong Q2 FY27 Financials
Indegene Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors, in its meeting held on October 29, 2026, approved these results.
Key Financial Highlights
Quarter and Half-Year Ended September 30, 2026
- Profit for the quarter: ₹1,123 million (compared to ₹1,021 million in the prior year period).
- Total Comprehensive Income for the quarter: ₹1,333 million.
- Profit for the half-year: ₹2,285 million (compared to ₹2,185 million in the prior year period).
- Total Comprehensive Income for the half-year: ₹2,613 million.
Board Decisions
Director Resignations Noted
The Board accepted the resignation of Mr. Mark Francis Dzialga from the position of Non-Executive – Non-Independent Director, effective October 29, 2026. The Board expressed its appreciation for his valuable contributions. Consequently, the Nomination and Remuneration Committee and Investment Committee have been reconstituted.
Additionally, the resignation of Ms. Srishti Ramesh Kaushik as Company Secretary, Compliance Officer, and Key Managerial Personnel was accepted. She will be relieved from her duties effective December 02, 2026. The Board also acknowledged her services and contributions.
Other Approvals
- Approval of unaudited Standalone and Consolidated Financial Results along with the Limited Review Report.
- Approval of allotment under RSU Scheme 2020 and ESOP Scheme 2020.
- Approved an amendment to the Prevention of Sexual Harassment Policy of the Company.
Trading Window Update
The Trading Window for dealing in the securities of the Company by its Designated Persons will reopen with effect from Monday, November 02, 2026, pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015.
Meeting Details
The Board of Directors’ meeting commenced at 06:30 PM (IST) and concluded at 07:16 PM (IST) on October 29, 2026. The information will be made available on the company’s website.
Source: BSE
